b‐AP15, an inhibitor of USP14 and UCHL5, exhibited potent tumour‐killing activity in BCR‐ABLWT and BCR‐ABLT315I CML cell lines, as well as in CML xenografts and primary CML cells. The gene discussed is UCHL5; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.